MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks

Invo Bioscience signs European distribution deal

November 13, 2019 By Sean Whooley Leave a Comment

Invo Bioscience (OTCQB:IVOB) announced that it entered into commercialization agreements covering Turkey and Jordan to support the company’s expansion into Eurasia. The commercialization agreements are in place to spread the Lakewood Ranch, Fla.–based company’s InvoCell in vivo fertility system to the Eurasia area. Invo Bioscience said research shows that an estimated 15% to 20% of the […]

Filed Under: Business/Financial News, Gynecological Tagged With: INVO Bioscience

Invo Bioscience wins CE Mark for InvoCell fertility device

October 28, 2019 By Sean Whooley Leave a Comment

INVO Bioscience (OTCQB:IVOB) said last week that it received CE Mark approval for its InvoCell culture and retention device as an alternative to traditional in vitro fertilization treatment. InvoCell won FDA de novo approval in November 2015 and was launched in the U.S. in April 2016. Currently, it is distributed throughout the U.S. under an $8 […]

Filed Under: Regulatory/Compliance, Women's Health Tagged With: INVO Bioscience

Nelipak names Roger Prevot CEO | Personnel Moves, Oct. 16, 2019

October 16, 2019 By Sean Whooley Leave a Comment

Nelipak Corp. said last week that Roger Prevot will take over as CEO, following the retirement of current CEO Michael Kelly. Kelly was in charge when private equity giant Kohlberg bought Nelipak for an undisclosed amount July 2. Kelly is retiring after overseeing the deal and positioning the company for the next phase of its […]

Filed Under: Business/Financial News, Featured Tagged With: Boston Scientific, conformis, electroCore, INVO Bioscience, Johnson and Johnson, Kohlberg Kravis Roberts & Co, Lyra Therapeutics, Miach Orthopaedics, Nelipak, Personnel Moves, Q'Apel Medical, Sientra

INVO Bioscience prices $13m offering

September 10, 2019 By Sean Whooley Leave a Comment

INVO Bioscience (OTCQB:IVOB) yesterday registered a common stock offering of more than $13 million, according to a regulatory filing. The Lakewood Ranch, Fla.-based company is putting up nearly 41 million shares of its common stock for close to $13.1 million. There are currently nearly 39 million outstanding shares, according to the filing. They are traded […]

Filed Under: Featured, Funding Roundup, Gynecological, News Well, Wall Street Beat, Women's Health Tagged With: INVO Bioscience

INVO Bioscience touts two women’s ability to carry the same baby

November 5, 2018 By Nancy Crotti Leave a Comment

INVO Bioscience today announced that a child had been born to a same-sex couple in which both partners were able to carry the baby in separate phases of the pregnancy. The couple, Bliss and Ashleigh Coulter of Mountain Springs, Texas, welcomed their son, Stetson, in late October. The women and their doctors used INVO Bioscience’s […]

Filed Under: Featured, Implants, Women's Health Tagged With: INVO Bioscience

Invo Bioscience launches InvoCell in US

April 20, 2016 By Fink Densford Leave a Comment

INVO Bioscience said today it launched its InvoCell intravaginal culture infertility treatment system in the U.S., starting in Texas through the Center for Assisted Reproduction. INVOcell is designed for incubating eggs and sperm during fertilization during early embryo development and operates within a woman’s body, unlike in vitro fertilization which takes place in a laboratory, the company […]

Filed Under: Business/Financial News, Regenerative Medicine Tagged With: INVO Bioscience

INVO Bioscience wins FDA de novo approval for InvoCell

November 4, 2015 By Fink Densford Leave a Comment

INVO Bioscience said yesterday it won FDA de novo approval for its INVOcell intravaginal culture infertility treatment system. The company said it is the 1st intravaginal culture system with marketing clearance in the U.S. INVOcell is designed for incubating eggs and sperm during fertilization during early embryo development and operates within a woman’s body, unlike in […]

Filed Under: Food & Drug Administration (FDA), Regenerative Medicine, Regulatory/Compliance, Women's Health Tagged With: INVO Bioscience

Medtronic wins 510(k) for surgical sealer | Regulatory Roundup

January 23, 2012 By MassDevice staff Leave a Comment

Medtronic
Salient Surgical

Medtronic (NYSE:MDT) won 510(k) clearance from the FDA for the Aquamantys surgical sealer it acquired when it paid $480 million for Salient Surgical Technologies last year.

Filed Under: 510(k), News Well Tagged With: Baxano Surgical, Cambridge Temperature Concepts, CareFusion Corp., Crux Biomedical, FzioMed, INVO Bioscience, MIM Software, Regulatory Roundup

Geron’s exit from stem cell business means opportunity for InVivo, others

November 16, 2011 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Filed Under: News Well, Regenerative Medicine, Wall Street Beat Tagged With: Aastrom Biosciences Inc, Amgen, Boston Scientific, Geron Corp., Imaging Diagnostic Systems, Intuitive Surgical, InVivo Therapeutics, INVO Bioscience, Pluristem, StemCells Inc., Steris Corp., Tengion Inc., The Cooper Cos., ThermoGenesis Corp.

Wall Street Beat: KCI alters debt deal with Apax – again

October 11, 2011 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Terms for the $6.3 billion leveraged buyout of Kinetic Concepts Inc. (NSYE:KCI) are in flux once again as the debt crisis in Europe roils credit markets.

KCI agreed in July to a $68.50-per-share LBO by Apax Partners and a pair of Canadian pension funds. The London-based PE firm and its partners planned to finance the buyout with about $5 billion in debt, backed by lenders Bank of America Corp., Credit Suisse Group AG and Morgan Stanley.

Filed Under: News Well, Wall Street Beat Tagged With: Apax Partners, Baxter, Covidien, Edwards Lifesciences, INVO Bioscience, Kinetic Concepts Inc., Natus Medical Inc., stjudemedical, Stryker

St. Jude gets Japanese go-ahead for smallest ICD and CRT in the industry

June 21, 2011 By MassDevice staff Leave a Comment

UnifyCRT

St. Jude Medical (NYSE:STJ) announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare for its Fortify implantable cardioverter defibrillator and Unify cardiac resynchronization therapy defibrillator, and the company launched the products in the Japanese market.

A ICD is an device that treats abnormally fast heart rhythms, and a CRT-D resynchronizes beating in the heart’s lower chambers, which often beat out of sync in heart failure patients.

Filed Under: Implants, News Well Tagged With: INVO Bioscience, Konica Minolta Opto Inc., Penumbra Inc., stjudemedical, X-spine Systems Inc.

  • 1
  • 2
  • Next Page »
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS